NM_016824.5:c.717+16T>G

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_016824.5(ADD3):​c.717+16T>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.229 in 1,608,486 control chromosomes in the GnomAD database, including 60,748 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.35 ( 14498 hom., cov: 32)
Exomes 𝑓: 0.22 ( 46250 hom. )

Consequence

ADD3
NM_016824.5 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 0.00900
Variant links:
Genes affected
ADD3 (HGNC:245): (adducin 3) Adducins are heteromeric proteins composed of different subunits referred to as adducin alpha, beta and gamma. The three subunits are encoded by distinct genes and belong to a family of membrane skeletal proteins involved in the assembly of spectrin-actin network in erythrocytes and at sites of cell-cell contact in epithelial tissues. While adducins alpha and gamma are ubiquitously expressed, the expression of adducin beta is restricted to brain and hematopoietic tissues. Adducin, originally purified from human erythrocytes, was found to be a heterodimer of adducins alpha and beta. Polymorphisms resulting in amino acid substitutions in these two subunits have been associated with the regulation of blood pressure in an animal model of hypertension. Heterodimers consisting of alpha and gamma subunits have also been described. Structurally, each subunit is comprised of two distinct domains. The amino-terminal region is protease resistant and globular in shape, while the carboxy-terminal region is protease sensitive. The latter contains multiple phosphorylation sites for protein kinase C, the binding site for calmodulin, and is required for association with spectrin and actin. Alternatively spliced adducin gamma transcripts encoding different isoforms have been described. The functions of the different isoforms are not known. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BP6
Variant 10-110118752-T-G is Benign according to our data. Variant chr10-110118752-T-G is described in ClinVar as [Benign]. Clinvar id is 1164946.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.738 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ADD3NM_016824.5 linkc.717+16T>G intron_variant Intron 6 of 14 ENST00000356080.9 NP_058432.1 Q9UEY8-1Q5VU08

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ADD3ENST00000356080.9 linkc.717+16T>G intron_variant Intron 6 of 14 1 NM_016824.5 ENSP00000348381.4 Q9UEY8-1

Frequencies

GnomAD3 genomes
AF:
0.354
AC:
53800
AN:
151974
Hom.:
14452
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.745
Gnomad AMI
AF:
0.132
Gnomad AMR
AF:
0.210
Gnomad ASJ
AF:
0.231
Gnomad EAS
AF:
0.407
Gnomad SAS
AF:
0.526
Gnomad FIN
AF:
0.148
Gnomad MID
AF:
0.275
Gnomad NFE
AF:
0.175
Gnomad OTH
AF:
0.317
GnomAD3 exomes
AF:
0.269
AC:
66780
AN:
248622
Hom.:
13260
AF XY:
0.275
AC XY:
36989
AN XY:
134262
show subpopulations
Gnomad AFR exome
AF:
0.753
Gnomad AMR exome
AF:
0.125
Gnomad ASJ exome
AF:
0.238
Gnomad EAS exome
AF:
0.398
Gnomad SAS exome
AF:
0.522
Gnomad FIN exome
AF:
0.154
Gnomad NFE exome
AF:
0.180
Gnomad OTH exome
AF:
0.224
GnomAD4 exome
AF:
0.216
AC:
314697
AN:
1456394
Hom.:
46250
Cov.:
31
AF XY:
0.224
AC XY:
162143
AN XY:
724004
show subpopulations
Gnomad4 AFR exome
AF:
0.767
Gnomad4 AMR exome
AF:
0.134
Gnomad4 ASJ exome
AF:
0.233
Gnomad4 EAS exome
AF:
0.412
Gnomad4 SAS exome
AF:
0.514
Gnomad4 FIN exome
AF:
0.150
Gnomad4 NFE exome
AF:
0.172
Gnomad4 OTH exome
AF:
0.261
GnomAD4 genome
AF:
0.354
AC:
53909
AN:
152092
Hom.:
14498
Cov.:
32
AF XY:
0.354
AC XY:
26327
AN XY:
74350
show subpopulations
Gnomad4 AFR
AF:
0.745
Gnomad4 AMR
AF:
0.209
Gnomad4 ASJ
AF:
0.231
Gnomad4 EAS
AF:
0.407
Gnomad4 SAS
AF:
0.525
Gnomad4 FIN
AF:
0.148
Gnomad4 NFE
AF:
0.175
Gnomad4 OTH
AF:
0.319
Alfa
AF:
0.265
Hom.:
1822
Bravo
AF:
0.369
Asia WGS
AF:
0.493
AC:
1713
AN:
3476

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: not provided

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.89
CADD
Benign
2.0
DANN
Benign
0.45

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.040
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs12268910; hg19: chr10-111878510; COSMIC: COSV53321271; COSMIC: COSV53321271; API